Psychical comorbidity and post-stationary treatmentadherence in patients after allogeneic stem cell transplantation

Psychical comorbidity and post-stationary treatmentadherence in patients after allogeneic stem cell transplantation - KMT study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00011762

Enrollment

Registered

2017-02-23

Start date

2012-05-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stem cell Transplantation

Interventions

Group 1: Every participant get to the following time points a set of questionnaires: questionnaire diagnosis prior transplantation (T0), TERS, adapted Version of SIRT

HADS-D, PHQ-D, SF-36, F-SozU (social support), external assessment of adherence through the treatend oncologist questionnaire diagnosis 3 months after the Transplantation (T1) MESI, HADS-D, PHQ-D, SF-

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Ambulant or stationary patients of the clinic for internal medicine I, for whom a allogenic stem cell transplantation is plannend; age: 18 - 75 years old; signed informed consent

Exclusion criteria

Exclusion criteria: no informed consent, 75 years

Design outcomes

Primary

Measure	Time frame
The treating oncologist performs Prior to the Transplantation and after 3. 12 and 36 months a assessment of the compliance through a 5-point Likert-scale. It shall be examined, if a assessment of adherence prior to the transplantation is possible. For this the Transplant Evaluation Rating Scale (TERS) shall be used to examine if a valide statement about the adherence after the transplantation can be formed. This would have positive effects on the prognosis of patients, but also it could help to avoid cost-intensive stationary residence of transplantation patients. Furthermore, a psychosomatic or psychooncological consulting or therapy would be possible prior to transplantation.	—

Measure

Time frame

The treating oncologist performs Prior to the Transplantation and after 3. 12 and 36 months a assessment of the compliance through a 5-point Likert-scale. It shall be examined, if a assessment of adherence prior to the transplantation is possible. For this the Transplant Evaluation Rating Scale (TERS) shall be used to examine if a valide statement about the adherence after the transplantation can be formed. This would have positive effects on the prognosis of patients, but also it could help to avoid cost-intensive stationary residence of transplantation patients. Furthermore, a psychosomatic or psychooncological consulting or therapy would be possible prior to transplantation.

—

Secondary

Measure	Time frame
Through 5 questionnaires shall further Parameters be examined, which could be related to the measured adherence (prior to the Transplantation and after 3, 12 and 36 months): MESI: handling with medicamentation, especially with immunosuppressives HADS-D: anxiety and Depression PHQ-D: Patient health qustionnaire SF-36: health status qustionnaire * F-SozU: social support	—

Countries

Germany

Contacts

Public ContactFrank Vitinius

Klinik für Psychosomatik und Psychotherapie der Uniklinik Köln

frank.vitinius@uk-koeln.de0049221 478 3171

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026